BLAINJECTIONINJECTABLEPriority Review
Approved
Mar 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ADAGEN (pegademase bovine) is a PEGylated adenosine deaminase enzyme replacement therapy administered by injection. It is indicated for adenosine deaminase (ADA) deficiency, a rare inherited metabolic disorder affecting the immune system. The drug works by replacing the deficient enzyme to restore purine metabolism and immune function.
LOE Approaching
With LOE approaching and limited linked job openings, this product faces commercial headwinds; teams are likely focused on lifecycle extension or transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ADAGEN offers deep expertise in orphan drug commercialization and rare disease management but limited career growth due to zero linked job openings and LOE approaching. This product is ideal for professionals seeking niche specialization in ultra-rare diseases or transition roles, rather than high-growth commercial environments.
Brand Manager (Orphan/Rare Disease)
Worked on ADAGEN at Leadiant Biosciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.